Incidence of erythromycin resistance in Streptococcus pyogenes: A 10-year study

Diagnostic Microbiology and Infectious Disease

Volumn 33, Issue 4, 1999, Pages 255-260

  Betriu, Carmen ^a   Casado, M Carmen ^a   Gómez, María ^a   Sanchez, Ana ^a   Palau, M Luisa ^a   Picazo, Juan J ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CEFOTAXIME; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; IMIPENEM; PENICILLIN G; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; INCIDENCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 0033000434     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(98)00155-2     Document Type: Article

References (37)

1. Barry A.L., Fuchs P.C., Brown S.D. Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA. J Antimicrob Chemother. 40:1997;139-140.
2. Betriu C., Cabronero M.C., Campos E., Fernández A., Picazo J.J. Sensibilidad a los antimicrobianos de estreptococo grupo A. Enferm Infecc Microbiol Clin. 76:1989;223-224.
3. Betriu C., Sánchez A., Gómez M., Cruceyra A., Picazo J.J. Antibiotic susceptibility of group A streptococci A 6-year follow-up study . Antimicrob Agents Chemother. 37:1993;1717-1719.
4. B resistance phenotype. J Antimicrob Chemother. 40:1997;85-90.
5. Borzani M., De Luca M., Varotto F. A survey of susceptibility to erythromycin amongst Streptococcus pyogenes isolates in Italy. J Antimicrob Chemother. 40:1997;457-458.
6. Carroll K.C., Monroe P., Cohen S., Hoffman M., Hamilton L., Korgenski K., Reimer L., Classen D., Daly J. Susceptibility of beta-hemolytic streptococci to nine antimicrobial agents among four medical centers in Salt Lake City, Utah, USA. Diagn Microbiol Infect Dis. 27:1997;123-128.
7. Cellesi C., Chigliotti S., Zanchi A., Mencarelli M., Corbisiero R., Rossoloni G.M. Susceptibility of macrolide and beta-lactam antibiotics of Streptococcus pyogenes strains isolated over a four-year period in central Italy. J Chemother. 8:1996;188-192.
8. Cercenado E, Sánchez-Carrillo C, García-Rey C, Bouza E (1997) Erythromycin-resistance in Streptococcus pyogenes and Streptococcus pneumoniae: High incidence of M phenotype among clinical isolates, abstr. E-110. p 133. In Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, Washington, D.C.
9. Chang S.C., Chen Y.C., Luh K.T., Hsieh W.C. Macrolides resistance of common bacteria isolated from Taiwan. Diagn Microbiol Infect Dis. 23:1995;147-154.
10. Cocuzza C.E., Mattina R., Mazzariol A., Orefici G., Rescaldani R., Primavera A., Bramati S., Masera G., Parizzi F., Cornaglia G., Fontana R. High incidence of erythromycin resistant Streptococcus pyogenes in Monza (North Italy) in untreated children with symptoms of acute pharyngo-tonsillitis An epidemiological and molecular study . Microb Drug Resist. 3:1997;371-378.
11. Coonan K.M., Kaplan E.L. In vitro susceptibility of recent North American Group A streptococcal isolates to eleven oral antibiotics. Pediatr Infect Dis J. 13:1994;630-635.
12. Cornaglia G, Ligozzi M, Mazzariol A, Valentini M, Orefici G, Fontana R (1996) Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. The Italian Surveillance Group for Antimicrobial Resistance Emerg Infect Dis 2:339-342.
13. Cornaglia G, Ligozzi M, Mazzariol A, Masala L, Lo Gascio G, Orefici G, Fontana R (1998) Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. The Italian Surveillance Group for Antimicrobial Resistance Clin Infect Dis 27(Supp 1):S87-S90.
14. Fujita K., Murono K., Yoshikawa M., Mural T. Decline of erythromycin resistance of group A streptococci in Japan. Pediatr Infect Dis J. 13:1994;1075-1078.
15. García-Bermejo I., Orden B., Cacho J., Alós J.I., Gómez-Garcés J.L. Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes in Madrid, Spain. Antimicrob Agents Chemother. 42:1998;989-990.
16. th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, Washington, D.C.
17. Hsueh P.-R., Chen H.-M., Huang A.-H., Wu J.-J. Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob Agents Chemother. 39:1995;2239-2242.
18. Kriebernegg I., Feierl G., Grisold A., Marth E. In-vitro susceptibility of group A beta-haemolytic streptococci (GABHS) to penicillin, erythromycin, clarythromycin and azithromycin in Styra, Austria. Zentralb Bakteriol. 278:1998;33-39.
19. Leclerq R., Courvalin P. Bacterial resistance to macrolide, lincosamide and streptogramin antibiotics by target modification. Antimicrob Agents Chemother. 35:1991;1267-1272.
20. Lopardo H.A., Venuta M.E., Vidal P., Rosaenz L., Corthey C., Farinati A., Couto E., Sarachian B., Sparo M., Kaufman S., De Mier C.A., Gubbay L., Scilingo V., Villaverde P. Argentinian collaborative study on prevalence of erythromycin and penicillin susceptibility in Streptococcus pyogenes. The Argentinian Streptococcus Study Group. Diagn Microbiol Infect Dis. 29:1997;29-32.
21. Lowbury E.J.L., Hurst L. The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin, and spiramycin. J Clin Pathol. 12:1959;163-169.
22. Maruyama S.H., Yoshioka H., Fujita K., Takimoto M., Satake Y. Sensitivity of group A streptococci to antibiotics. Am J Dis Child. 133:1979;1143-1145.
23. National Committee for Clinical Laboratory Standards (1997) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A4. Villanova, PA: NCCLS.
24. Orden B., Pérez-Trallero E., Montes M., Martínez R. Erythromycin resistance of Streptococcus pyogenes in Madrid. Pediatr Infect Dis J. 17:1998;470-473.
25. Pérez-Trallero E., Urbieta M., Montes M., Ayestaran I., Marimon J.M. Emergence of Streptococcus pyogenes strains resistant to erythromycin in Guipuzkoa, Spain. Eur J Clin Microbiol Infect Dis. 17:1998;25-31.
26. Phillips G., Parratt D., Orange G.V., Harpaer L., McEwan H., Young N. Erythromycin-resistant Streptococcus pyogenes. J Antimicrob Chemother. 25:1990;723-724.
27. Seppälä H., Nissinen A., Järvinen H., et al. Resistance to erythromycin in group A streptococci. N Engl J Med. 326:1992;292-297.
28. Seppälä H., Nissinen A., Yu Q., Huovinen P. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother. 32:1993;885-891.
29. Seppälä H., Klaukka T., Lehtonen R., Nenonen E., the Finnish Study Group for Antimicrobial resistance , Huovinen P. Outpatient use of erythromycin link to increased erythromycin resistance in group A streptococci . Clin Infect Dis. 21:1995;1378-1385.
30. Seppälä H., Klaukka T., Vuopio-Varkila J., Muotiala A., Helenus H., Lager K., Huovinen P., the Finnish Study Group for Antimicrobial Resistance . The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med. 337:1997;441-446.
31. Stingemore N., Francis G.R., Toohey M., McGechie D.B. The emergence of erythromycin resistance in Streptococcus pyogenes in Fremantle, Western Australia. Med J Aust. 150:1989;626-631.
32. Stevens D.L., Tanner M.H., Winship J., Swarts J.R., Reis K.M., Schlievert P.M., Kaplan E. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med. 321:1989;1-7.
33. Stutcliffe J., Tait-Kamradt A., Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother. 40:1996;1817-1824.
34. Traub W.H., Leonhard B. Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolityc streptococcal isolates to 24 antimicrobial drugs. Chemotherapy. 43:1997;10-20.
35. van Asselt G.J., Sloos J.H., Mouton R.P., van Boven C.P.A., van de Klundert J.A.M. Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro. J Med Microbiol. 43:1995;386-391.
36. Veasy G.L., Tany L.Y., Hill H.R. Persistence of acute rheumatic fever in the intermountain area of the United States. J Pediatr. 124:1994;9-16.
37. Weiss I., Gorodnitzky Z., Korenman Z., Yagupsky P. Serotyping and susceptibility to macrolides and other antimicrobial drugs of Streptococcus pyogenes isolated from patients with invasive diseases in southern Israel. Eur J Clin Microbiol Infect Dis. 16:1997;20-23.